Aclaris Therapts (ACRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 19,167 | 28,660 | 19,960 | 25,256 | 25,402 |
| Marketable Securities | 72,389 | 76,756 | 70,791 | 70,656 | 74,404 |
| Receivables | 6,209 | 4,814 | 5,565 | 4,680 | 194 |
| TOTAL | $97,765 | $110,230 | $96,316 | $100,592 | $104,202 |
| Non-Current Assets | |||||
| PPE Net | 664 | 750 | 761 | 811 | 868 |
| Investments And Advances | 79,065 | 85,372 | 60,612 | 71,297 | 81,084 |
| Other Non-Current Assets | 2,199 | 2,368 | 2,771 | 2,834 | 2,993 |
| TOTAL | $81,928 | $88,490 | $64,144 | $74,942 | $84,945 |
| Total Assets | $179,693 | $198,720 | $160,460 | $175,534 | $189,147 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 15,516 | 14,731 | 13,158 | 9,187 | 8,797 |
| Accrued Expenses | 5,959 | 5,896 | 8,791 | 9,784 | 11,411 |
| TOTAL | $28,241 | $27,370 | $28,645 | $25,631 | $26,839 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 3,976 | 3,972 | 3,943 | 3,925 | 3,914 |
| Other Non-Current Liabilities | 12,562 | 12,416 | 12,565 | 12,311 | 12,351 |
| TOTAL | $26,871 | $27,701 | $28,733 | $29,803 | $30,569 |
| Total Liabilities | $55,112 | $55,071 | $57,378 | $55,434 | $57,408 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 147,199 | 139,664 | 120,595 | 108,345 | 108,332 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -1,009,113 | -987,608 | -967,784 | -947,989 | -933,375 |
| Other shareholders' equity | -304 | 22 | 610 | 597 | 482 |
| TOTAL | $124,581 | $143,649 | $103,082 | $120,100 | $131,739 |
| Total Liabilities And Equity | $179,693 | $198,720 | $160,460 | $175,534 | $189,147 |